GENOMIND PRESENTS WEBINAR SHOWCASING BENEFITS OF THE GENECEPT™ ASSAY
CHALFONT, PA – October 9, 2012—Genomind is pleased to announce that on October 9 and 10, 2012, they will host a complimentary educational webinar featuring Dr. Jay Lombard, Chief Scientific Officer and Medical Director. All those interested in learning more about biomarkers in psychiatry are invited to join.
Dr. Lombard will present a session about the importance of biomarkers in psychiatry, and the clinical application and benefits provided by Genomind’s Genecept Assay. The Assay is a simple to use, saliva-based test which analyzes a patient’s genetic make-up to help inform clinician treatment decisions for difficult to treat patients with psychiatric diagnoses. Dr. Lombard will discuss the proprietary 10 gene panel, and share the results from recent case studies to show how other clinicians are using the Assay in their practices.
A hallmark of Genomind’s commitment to discovery, product development, and improvement of patient outcomes is education. This webinar will not only update clinicians on the latest research in their field, but also give them the information they need to implement the Genecept Assay into their own practices.
WHAT: Webinar on the Use of Biomarkers for Patient Psychiatric Care: The Value of the Genecept Assay
DATE: Tuesday, October 9, 2012 at 2:00 PM
WHERE: Contact firstname.lastname@example.org for a link to access the day/time you prefer
MEDIA CONTACT: Doreen Korba, Director of Marketing
Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients’ lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research. Learn more at http://www.genomind.com.
About the Genecept™ Assay
The Genecept Assay is a comprehensive, simple-to-use tool for understanding genetic and biological markers that best inform response to different psychiatric treatments. The Assay is Genomind’s core product, and contains a proprietary panel of biomarker tests, an analytic report, and a psychopharmacologist consultation. The Assay can be used for a range of psychiatric conditions including depression, bipolar disorder, schizophrenia, anxiety disorders, OCD and ADHD. For more information on the Assay, including information about the specific genes in the panel, please visit http://www.genomind.com/products/assay.